GM-CSF Receptor Alpha Chain

GM-CSF Receptor Alpha Chain

Introduction

Granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor alpha chain (CSF2RA) is a critical cell surface receptor that mediates the pleiotropic effects of GM-CSF on myeloid lineage cells. While initially characterized for its role in hematopoiesis and immune cell development, emerging research has revealed important functions for the GM-CSF receptor system in the central nervous system, particularly in microglia-mediated neuroinflammation and neurodegenerative disease pathogenesis.

GM-CSF Receptor Alpha Chain

Introduction

Granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor alpha chain (CSF2RA) is a critical cell surface receptor that mediates the pleiotropic effects of GM-CSF on myeloid lineage cells. While initially characterized for its role in hematopoiesis and immune cell development, emerging research has revealed important functions for the GM-CSF receptor system in the central nervous system, particularly in microglia-mediated neuroinflammation and neurodegenerative disease pathogenesis.

<div class="infobox infobox-protein"> [@hamilton2008]
<table> [@becher2016]
<tr><th colspan="2" style="background:#f8f9fa;text-align:center;font-size:1.2em;">CSF2RA</th></tr> [@ling2015]
<tr><td colspan="2" style="text-align:center;font-style:italic;">GM-CSF Receptor Alpha Chain</td></tr>
<tr><th style="width:40%;">Protein Name</th><td>GM-CSF Receptor Alpha Chain</td></tr>
<tr><th>Gene</th><td>[CSF2RA](/genes/csf2ra)</td></tr>
<tr><th>UniProt ID</th><td>[P15509](https://www.uniprot.org/uniprot/P15509)</td></tr>
<tr><th>PDB ID</th><td>[2GYS](https://www.rcsb.org/structure/2GYS)</td></tr>
<tr><th>Molecular Weight</th><td>85 kDa (predicted)</td></tr>
<tr><th>Subcellular Localization</th><td>Plasma membrane</td></tr>
<tr><th>Protein Family</th><td>Hematopoietic cytokine receptor family</td></tr>
<tr><th>Expression</th><td>Myeloid cells, microglia, neurons</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">44 edges</a></td>
</tr>
</table>
</div>

Gene and Protein Structure

Gene Organization

The human CSF2RA gene is located on the X chromosome (Xp22.32) and spans approximately 15.5 kb. The gene consists of 14 exons encoding a type I transmembrane protein. Alternative splicing generates multiple transcript variants with distinct expression patterns.

Protein Domain Architecture

CSF2RA possesses a characteristic cytokine receptor domain structure [@wu2000]:

• Extracellular Domain (1-320 aa): Contains the cytokine-binding consensus (CBC) domain with the hallmark WSXWS motif (positions 241-245). This motif is critical for proper protein folding and ligand binding. The extracellular region also contains three N-linked glycosylation sites.
• Transmembrane Domain (321-343 aa): A single hydrophobic alpha-helical transmembrane segment anchors the receptor in the plasma membrane.
• Intracellular Domain (344-400 aa): A short cytoplasmic tail lacking intrinsic kinase activity. Signal transduction requires recruitment of the common beta chain (CSF2RB) and associated Janus kinases.

Structural Features

The crystal structure of the GM-CSF receptor extracellular domain reveals:

• A fibronectin type III-like fold common to cytokine receptors
• Two distinct ligand-binding sites with different affinities
• A flexible hinge region allowing conformational changes upon ligand binding

Signal Transduction Pathways

JAK2/STAT5 Pathway

Binding of GM-CSF to the high-affinity receptor complex triggers activation of JAK2 tyrosine kinases constitutively associated with the cytoplasmic domain of CSF2RB. This leads to:

MAPK/ERK Pathway

GM-CSF receptor signaling also activates the Ras/Raf/MEK/ERK cascade:

PI3K/Akt Pathway

The PI3K pathway provides survival signals:

Cross-talk with Other Pathways

The GM-CSF receptor system exhibits significant cross-talk with:

• TLR signaling: GM-CSF priming enhances TLR-induced inflammatory responses in microglia
• Notch signaling: CSF2RA expression influences Notch-mediated fate decisions in neural progenitors
• Cytokine networks: Interacts with IL-34 and M-CSF receptor pathways

Expression in the Central Nervous System

Microglial Expression

CSF2RA is expressed at high levels on microglia throughout the brain [@kettenmann2011]. Microglial expression of CSF2RA is upregulated in response to:

• Aging
• [Neuroinflammation](/mechanisms/neuroinflammation) Neurodegeneration (AD, PD, ALS)
• Brain injury

• Hippocampus (CA1, dentate gyrus)
• Cerebral cortex (layers 2-3, 5-6)
• Subventricular zone
• Cerebellum (Purkinje cell layer)

Neuronal Expression

Interestingly, recent studies have detected CSF2RA expression on subsets of neurons, particularly:

• Cortical pyramidal neurons
• Hippocampal granule cells
• Cerebellar Purkinje cells

• Synaptic plasticity
• Neuronal survival
• Neuroprotection

Expression in Other Glial Cells

• Astrocytes: Low basal expression, upregulated in reactive astrocytes
• Oligodendrocyte precursor cells (OPCs): CSF2RA expression during development
• Endothelial cells: Expression in brain vasculature

Role in Microglia Biology

Microglia Development and Maintenance

GM-CSF signaling through CSF2RA is essential for:

Microglial Activation

CSF2RA signaling modulates microglial activation states:

Pro-inflammatory (M1-like) phenotype:

• Enhanced production of TNF-α, IL-1β, IL-6
• Increased expression of MHC class II
• Enhanced phagocytosis
• Production of reactive oxygen species (ROS)

• IL-10 production
• TGF-β secretion
• Arginase-1 expression
• Tissue repair functions

Chemotaxis and Migration

GM-CSF acts as a microglial chemoattractant:

• Directs microglial migration toward sites of injury
• Promotes accumulation at amyloid plaques in AD
• Mediates microglial recruitment in PD models

Role in Neurodegenerative Diseases

Alzheimer's Disease

GM-CSF/CSF2RA signaling plays a complex role in AD pathogenesis [@boche2013]:

Amyloid pathology:

• GM-CSF promotes microglial recruitment to amyloid plaques
• Enhanced phagocytosis of Aβ by GM-CSF-stimulated microglia
• Potential for therapeutic modulation of microglial function

• GM-CSF signaling may influence tau phosphorylation
• Cross-talk with GSK-3β signaling pathway

• CSF2RA upregulation in AD microglia
• Contribution to chronic neuroinflammation
• Potential dual role: protective vs. detrimental

• GM-CSF as potential therapeutic: promotes plaque clearance in mouse models
• Anti-CSF2RA antibodies: being developed to dampen inflammation
• Phase I/II clinical trials for GM-CSF in AD (sargramostim)

Parkinson's Disease

In PD, CSF2RA signaling contributes to:

Dopaminergic neuron survival:

• GM-CSF promotes survival of dopaminergic neurons in vitro
• In vivo: protects against MPTP-induced degeneration

• CSF2RA+ microglia in substantia nigra
• Contributes to chronic neuroinflammation
• May accelerate disease progression

• GM-CSF enhances microglial uptake of α-synuclein
• May influence spread of pathology

• GM-CSF trials in PD patients
• Neuroprotective effects observed in preclinical models

Amyotrophic Lateral Sclerosis

CSF2RA signaling in ALS:

• Upregulated on microglia in ALS models and patients
• Contributes to non-cell autonomous toxicity
• Therapeutic targeting under investigation

Multiple Sclerosis

GM-CSF/CSF2RA has a well-established role in MS pathogenesis:

• CSF2RA genetic variants associated with MS susceptibility
• GM-CSF drives Th17 differentiation
• Microglial activation in demyelinating lesions
• CSF2RA as therapeutic target ( ClinicalTrials.gov: NCT03822650)

Stroke and Brain Injury

Following stroke and traumatic brain injury:

• Rapid CSF2RA upregulation on microglia
• Mediates inflammatory response
• Influences repair and regeneration
• Potential for intervention to modulate outcomes

Therapeutic Targeting

GM-CSF Agonists

Sargramostim (GM-CSF):

• Clinical trials in AD (phase I/II completed)
• Phase II in PD
• Potential for enhancing microglial function
• Side effects: flu-like symptoms, myalgia

CSF2RA Antagonists

Blocking antibodies:

• Anti-CSF2RA antibodies in development
• Goal: dampen pathogenic inflammation

• CSF2RA signaling inhibitors
• Targeted approach to reduce neuroinflammation

Modulation Strategies

Genetics and Variants

CSF2RA Polymorphisms

Single nucleotide polymorphisms (SNPs) in CSF2RA have been associated with:

• Multiple sclerosis susceptibility
• Response to GM-CSF therapy
• Autoimmune disease predisposition

Disease-Causing Mutations

Rare mutations in CSF2RA cause:

• Pulmonary alveolar proteinosis (PAP)
• Combined immunodeficiencies
• Rare neurological manifestations

Comparative Biology

Species Conservation

CSF2RA is evolutionarily conserved across mammals:

• Human and mouse: ~75% amino acid identity
• Critical functional domains highly conserved
• Enables translational research in mouse models

Receptor Evolution

The GM-CSF receptor family arose through gene duplication:

• CSF2RA and CSF2RB arose from common ancestor
• IL3RA and IL5RA share similar domain architecture
• Reflects evolutionary pressure to expand cytokine signaling

Research Methods

Detection Techniques

• Immunohistochemistry: CSF2RA detection in brain tissue
• Flow cytometry: Surface expression on cultured microglia
• Western blot: Protein level analysis
• RT-qPCR: mRNA expression studies
• Single-cell RNA-seq: Cellular expression patterns

Experimental Models

• In vitro: Primary microglial cultures, cell lines
• In vivo: Transgenic mice, knockouts, reporter lines
• Human: Post-mortem brain tissue, iPSC-derived cells

Future Directions

Key questions remain regarding CSF2RA in the nervous system:

Cross-Links

• [CSF2RA Gene](/genes/csf2ra)
• [GM-CSF](/entities/gm-csf)
• [Microglia](/cell-types/microglia)
• [Neuroinflammation](/mechanisms/neuroinflammation-pathway)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Multiple Sclerosis](/diseases/multiple-sclerosis)
• [Cytokine Signaling](/mechanisms/cytokine-signaling)

See Also

• [CSF2RA Gene](/genes/csf2ra)
• [GM-CSF](/entities/gm-csf)
• [Multiple Sclerosis](/diseases/multiple-sclerosis)
• [Cytokine Signaling in Neurodegeneration](/mechanisms/cytokine-signaling)

External Links

• [UniProt: CSF2RA](https://www.uniprot.org/uniprot/P15509)
• [PDB: 2GYS](https://www.rcsb.org/structure/2GYS)
• [GeneCards: CSF2RA](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CSF2RA)
• [Human Protein Atlas: CSF2RA](https://www.proteinatlas.org/gene/CSF2RA)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving GM-CSF Receptor Alpha Chain discovered through SciDEX knowledge graph analysis: